Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 40

Heliox to ease breathing and sharpen thinking when breathing is hard

Official title: Optimizing Mind-Body Interactions in Respiratory Control During Operationally Relevant Environmental Stressors

Run by Indiana University · NCT07424014 · Data updated 2026-11-12

This trial will test whether breathing heliox (a low-density gas mix) reduces breathing effort and improves reaction time and accuracy in healthy adults exposed to increased inspiratory resistance.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment15 (estimated)
SponsorIndiana University
Academic / other
Locations1 site (Bloomington, Indiana)
StatusRecruiting
StartedFebruary 3, 2026
Main results expectedMay 31, 2027
Study endsMay 31, 2027
Registry record updatedMarch 12, 2026
Trial IDNCT07424014 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are healthy, English-speaking adults aged 18–40 who are regularly active (≥120 minutes/week high-intensity exercise), with normal pulmonary and cognitive test results and BMI ≤35 kg/m2.

Probably not a fit

People with chronic lung, cardiovascular, renal, neurological, or metabolic disease, smokers, pregnant individuals, those on excluded medications, or those with abnormal lung or cognitive screening are not eligible and are unlikely to benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional Phase 4 trial enrolls healthy, physically active adults aged 18–40 with normal lung and cognitive function to compare heliox versus normal-density air during controlled inspiratory resistance. Participants complete a screening/familiarization visit and a main experimental visit where they perform attention-demanding reaction-time tasks and report breathing perception while breathing under elevated inspiratory loads. Heliox is used because its low density reduces turbulent airway flow and the resistive work of breathing, allowing the study to isolate whether lowering mechanical load improves cognitive performance and reduces dyspnea. Outcomes include measures of perceived breathing effort, reaction time, accuracy, and lung mechanics.

Why it matters

Potential benefit: If successful, the approach could reduce breathing discomfort and improve cognitive performance during high-resistance breathing situations, potentially improving operational performance for Warfighters.

How similar studies have gone: Prior physiological and clinical work shows heliox lowers resistive work of breathing, but its direct effects on cognitive performance during inspiratory resistance have been less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Between the ages of 18-40 years old.
* English speaking and reading.
* Self-reported weekly activity of at least 120 minutes/week of high intensity exercise for the previous 2 years.
* Normal pulmonary function assessed by a resting forced expiratory volume in 1 second over forced vital capacity (FEV1/FVC) \> 75% of predicted.
* Normal cognitive function assessed using the Montreal cognitive function test \[18\].
* Body mass index (BMI) ≤ 35 kg/m2.
* Females with a regular menstrual cycle that ranges from 21-35 days (eumenorrhea)

Exclusion Criteria:

* History of smoking or recreational smoking, cardiovascular disease, renal disease, pulmonary disease (including asthma or exercise-induced asthma), neurological disease, and metabolic disease.
* Are pregnant or could possibly be pregnant by self-report.
* Are color blind.
* Known allergy or hypersensitivity latex.
* Take selective serotonin reuptake inhibitors, stimulant medication, antibiotics, and chronically consume pain medication (Aleve, Tylenol, etc.).
* Resting blood pressure of \> 130mmHg systolic or 90 mmHg diastolic and/or resting pulse rate of \> 100 bpm.
* Females with irregular menstrual cycles (oligomenorrhea) that ranges from 36-90 days, and females with the absence of a menstrual cycle (amenorrhea).
* Taking birth control for the sole purpose of period cessation (eg., Mirena IUD)

Where it's running

  • Multidisciplinary Engineering and Sciences Hall (MESH)
    Bloomington, Indiana, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.